The U.S. Food and Drug Administration has approved Onapgo, a continuous apomorphine hydrochloride infusion, for the treatment of motor fluctuations in adult patients with advanced Parkinson’s disease.
A medical advocacy group sues U.S. health agencies over the removal of public health data in response to an executive order targeting 'gender ideology extremism.' The lawsuit seeks to reinstate the removed webpages and challenges an OPM memorandum, naming the CDC, FDA, and HHS as defendants.
New research shows propranolol, a commonly used blood pressure and migraine medication, may cut ischemic stroke risk by up to 52% in women with migraines—particularly those without aura—while showing no protective effect in men.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Clemson University is addressing health care needs in rural South Carolina, where uninsured patients, linguistic preferences, and limited Medicaid expansion pose challenges. Learn about their initiatives to improve health care access.
No significant difference in survival or neurologic outcomes between intraosseous and intravenous vascular access in out-of-hospital cardiac arrest was found.
A new computer vision test measuring children's dance-like movements distinguishes autism from ADHD with 80% accuracy, without requiring wearable sensors or manual coding.